General MedicationsORALGeneric
AGENERASE
AMPRENAVIR
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview AGENERASE is listed in Drugs@FDA under application 021007 (NDA).
Marketing status: Discontinued Active ingredient AMPRENAVIR Form and strength CAPSULE;ORAL - 50MG Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2005-11-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview AGENERASE is listed in Drugs@FDA under application 021007 (NDA). Marketing status: Discontinued Active ingredient AMPRENAVIR Form and strength CAPSULE;ORAL - 50MG Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2005-11-04 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.